Clinical Trials Browser

Phase 3 × Unknown × Vinorelbine × Clear all

NCT04400695 2024-01-24

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Phase 3 Unknown

Breast Neoplasms

NCT02465736 2024-01-16

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

Phase 3 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02448797 2021-07-20

EVIDENCE

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04665986 2020-12-14

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT04307147 2020-03-13

NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy

Phase 3 Unknown

Breast Neoplasms

NCT03656393 2018-09-04

RCTACSCNSCLC

Phase 3 Unknown

NSCLC

NCT03359694 2017-12-02

Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer

Phase 3 Unknown

Breast Neoplasms, Genetic Predisposition to Disease

NCT03006614 2017-01-16

PERS

Phase 3 Unknown

Breast Neoplasms

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02281708 2014-11-03

Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma

Phase 3 Unknown

Lung Neoplasms, Recurrence

NCT00003447 2013-12-19

Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003240 2013-12-18

Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00004100 2013-12-18

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00379457 2013-08-12

Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

Phase 3 Unknown

Malignant mesenchymal tumor, Sarcoma

NCT01126138 2011-05-04

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Phase 3 Unknown

Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

NCT00430001 2008-05-09

Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00265694 2005-12-15

Random Trial for Elderly Patients With NSCLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung